DEG-35

Skip to product information
1 of 1

Selleck Chemicals

SKU:E1412-5MG

Regular price €144,00 EUR
Regular price Sale price €144,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

DEG-35 is a modulator of CK2 used in studies of kinase signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to phosphorylation signaling, target engagement, and selectivity relationships in cancer, cell signaling, and metabolism models.

By modulating CK2, DEG-35 can be used to examine phosphorylation signaling, target engagement, and selectivity relationships. This target class is commonly examined through biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping. In cancer, cell signaling, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving CK2
  • Context-dependent response profiling and mechanism comparison
  • Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
  • Phenotypic profiling in cancer, cell signaling, and metabolism models

Overall, DEG-35 is appropriate when a defined chemical perturbant is needed to connect CK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
CK2
Target Class:
Kinase
Research Area:
Cancer • Cell Signaling • Metabolism
Molecular Weight:
443.45
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.